Argatroban anticoagulation in obese versus nonobese patients: Implications for treating heparin-induced thrombocytopenia

被引：19
|
作者：
Rice, Lawrence
Hursting, Marcie J.
Baillie, G. Mark
McCollum, David A.
机构：
[1] Methodist Hosp, Weill Cornell Med Coll, Houston, TX 77030 USA
[2] Clin Sci Consulting, Austin, TX USA
[3] CTI Clin Trial & Consulting Serv, Cincinnati, OH USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2007年 / 47卷 / 08期
关键词：
heparin-induced thrombocytopenia; obesity; argatroban; body mass index; thrombosis;
D O I：
10.1177/0091270007302951
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1028 / 1034
页数：7
相关论文
共 50 条
  • [41] Anticoagulation in patients with heparin-induced thrombocytopenia type II
    Harenberg, J
    Huhle, G
    Piazolo, L
    Wang, LCU
    Heene, DL
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (02): : 189 - 196
  • [42] Recombinant hirudin anticoagulation in patients with heparin-induced thrombocytopenia
    Schiele, F
    Vuillemenot, A
    Mouhat, T
    Kieffer, Y
    Anguenot, T
    Bernard, Y
    Bassand, JP
    PRESSE MEDICALE, 1996, 25 (16): : 757 - 760
  • [43] Lepirudin anticoagulation for heparin-induced thrombocytopenia
    Deitcher, SR
    Topoulos, AP
    Bartholomew, JR
    Kichuk-Chrisant, MR
    JOURNAL OF PEDIATRICS, 2002, 140 (02): : 264 - 266
  • [44] Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices
    Pappalardo, F.
    Scandroglio, A. M.
    Potapov, E.
    Stepanenko, A.
    Maj, G.
    Krabatsch, T.
    Zangrillo, A.
    Koster, A.
    Hetzer, R.
    MINERVA ANESTESIOLOGICA, 2012, 78 (03) : 330 - 335
  • [45] Argatroban for anticoagulation in children with heparin-induced platelet antibodies
    Liedel, JL
    Panicker, N
    Kahana, MD
    CRITICAL CARE MEDICINE, 2003, 31 (12) : A132 - A132
  • [46] Argatroban for anticoagulation in children with heparin-induced platelet antibodies
    Panicker, N
    Liedel, JL
    Kahana, MD
    PEDIATRIC RESEARCH, 2004, 55 (04) : 287A - 287A
  • [47] Efficacy and Safety of Argatroban and Bivalirudine in Patients with Suspected Heparin-Induced Thrombocytopenia
    Vo, Quynh-Anh T.
    Lin, Joyce K.
    Tong, Lisa M.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (02) : 178 - 184
  • [48] A META-ANALYSIS OF BIVALIRUDIN VERSUS ARGATROBAN FOR THE TREATMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA
    Rivner, Harold
    Parmar, Rajiv
    Cardoso, Rhanderson
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 2064 - 2064
  • [49] Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia
    Marchetti, Matteo
    Barelli, Stefano
    Gleich, Tobias
    Gomez, Francisco J.
    Goodyer, Matthew
    Grandoni, Francesco
    Alberio, Lorenzo
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (06) : 766 - 790
  • [50] Argatroban as Purge Solution in Patients With Heparin-Induced Thrombocytopenia on an Impella Device
    Mir, Tanveer
    Changal, Khalid Hamid
    Smith, Antonio
    Ambreen, Sabah
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (06) : E763 - E765
12345